Ravina Bernard 4
4 · Praxis Precision Medicines, Inc. · Filed Jan 5, 2021
Insider Transaction Report
Form 4
Ravina Bernard
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-01-04$2.27/sh+45,000$102,150→ 56,021 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-01-04$2.27/sh−45,000$102,150→ 139,479 totalExercise: $2.27Exp: 2028-10-18→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]25% of this option vested and became exercisable on August 21, 2019, with the remainder vesting in 36 equal monthly installments thereafter. This option was initially for 195,500 shares and the Reporting Person has exercised his option to purchase 56,021 shares since such grant date.